Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ypsomed Group
FDA Clears Abbott’s Modified CGM For Automated Insulin Delivery Integration, Label Expansion
Abbott announced today it plans to integrate its FDA-cleared modified CGMs with insulin pump makers, including Tandem and Insulet, likely later this year.
Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021
The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021.
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
- Ypsotec Ag, DiaExpert GmbH, Florian Muller GmbH, Ypsomed, Ypsomed Distribution AG
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.